pyrazolanthrone has been researched along with quercetagetin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bu, F; Ouyang, L; Pan, X; Pei, J; Shuai, W; Wang, A; Wang, G; Wu, Y; Zhao, M; Zhu, Y | 1 |
| Arciniega, M; Augustin, M; Baek, S; Bode, AM; Byun, S; Dong, Z; Heo, YS; Holak, TA; Huber, R; Jung, SK; Kang, NJ; Kim, BY; Lee, HJ; Lee, KW; Popowicz, GM; Song, NR | 1 |
2 other study(ies) available for pyrazolanthrone and quercetagetin
| Article | Year |
|---|---|
Unraveling the Design and Discovery of c-Jun N-Terminal Kinase Inhibitors and Their Therapeutic Potential in Human Diseases.
Topics: Humans; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Neoplasms; Phosphorylation; Protein Isoforms | 2022 |
Structural and functional analysis of the natural JNK1 inhibitor quercetagetin.
Topics: Adaptor Proteins, Signal Transducing; Adenosine Triphosphate; Animals; Anthracenes; Binding, Competitive; Cell Transformation, Neoplastic; Chromones; Crystallography, X-Ray; Flavones; Humans; Mice; Mice, Hairless; Mitogen-Activated Protein Kinase 8; Models, Molecular; Molecular Dynamics Simulation; NF-kappa B; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Conformation; Proto-Oncogene Proteins c-akt; Skin Neoplasms; Transcription Factor AP-1; Ultraviolet Rays | 2013 |